2003
DOI: 10.1172/jci200317429
|View full text |Cite
|
Sign up to set email alerts
|

Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease

Abstract: Neuronal nicotinic AChRs (nAChRs) are implicated in the pathogenesis of diverse neurological disorders and in the regulation of small-cell lung carcinoma growth. Twelve subunits have been identified in vertebrates, and mutations of one are recognized in a rare form of human epilepsy. Mice with genetically manipulated neuronal nAChR subunits exhibit behavioral or autonomic phenotypes. Here, we report the first model of an acquired neuronal nAChR disorder and evidence for its pertinence to paraneoplastic neurolo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
68
0
3

Year Published

2003
2003
2017
2017

Publication Types

Select...
10

Relationship

6
4

Authors

Journals

citations
Cited by 53 publications
(71 citation statements)
references
References 30 publications
0
68
0
3
Order By: Relevance
“…M1 and M23 cDNAs and stably transfected clones of HEK-293 were produced as described (2,4). DNA encoding AQP4 extracellular loop C was PCR amplified and cloned into pET 4T vector (Stratagene) to produce and purify GST-ECD-C fusion protein (26).…”
Section: Methodsmentioning
confidence: 99%
“…M1 and M23 cDNAs and stably transfected clones of HEK-293 were produced as described (2,4). DNA encoding AQP4 extracellular loop C was PCR amplified and cloned into pET 4T vector (Stratagene) to produce and purify GST-ECD-C fusion protein (26).…”
Section: Methodsmentioning
confidence: 99%
“…Further, GluR3 has a granzyme B site at the autoimmune epitope. 81 Lennon et al 82 have suggested that immune responses generated against nAChR may also result in seizure and dementia.…”
Section: Immune Systemmentioning
confidence: 99%
“…1 Ganglionic ␣3 nicotinic acetylcholine receptor (nAChR) antibodies are found in serum of about half of reported cases, correlate to disease severity, and have been shown to be pathogenic. [2][3][4][5][6][7] Accordingly, AAG has been shown to respond to immunotherapy with IV immunoglobulin, plasma exchange, and immunosuppressants. 8 It has been reported that 74% of ␣3 nAChR patients have clinically significant issues with thermoregulation including reduced sweating and heat intolerance.…”
mentioning
confidence: 99%